Medikaloka Hermina Tbk PT
IDX:HEAL
Medikaloka Hermina Tbk PT
IDX:HEAL
Price:
1 535
IDR
1.99%
Market Cap:
23.6T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
HEAL Alert
Medikaloka Hermina Tbk PT
1535
+30 (+1.99%)
| 52 Week Range |
1 070
1 595
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Medikaloka Hermina Tbk PT
Income Statement
Earnings Waterfall
Medikaloka Hermina Tbk PT
Medikaloka Hermina Tbk PT
|
Revenue
|
6.6T
IDR
|
|
Cost of Revenue
|
-4.2T
IDR
|
|
Gross Profit
|
2.4T
IDR
|
|
Operating Expenses
|
-1.4T
IDR
|
|
Operating Income
|
1T
IDR
|
|
Other Expenses
|
-487.9B
IDR
|
|
Net Income
|
556.7B
IDR
|
Income Statement
Medikaloka Hermina Tbk PT
Medikaloka Hermina Tbk PT
Currency: IDR
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Revenue |
2 911 813
N/A
|
3 002 728
+3%
|
3 058 091
+2%
|
3 213 504
+5%
|
3 330 819
+4%
|
3 457 550
+4%
|
3 630 940
+5%
|
3 713 290
+2%
|
3 574 963
-4%
|
3 826 030
+7%
|
4 416 042
+15%
|
5 017 031
+14%
|
5 782 130
+15%
|
6 160 265
+7%
|
5 820 123
-6%
|
5 428 057
-7%
|
5 050 988
-7%
|
4 784 294
-5%
|
4 901 810
+2%
|
5 061 594
+3%
|
5 264 144
+4%
|
5 540 483
+5%
|
5 784 086
+4%
|
6 137 900
+6%
|
6 436 894
+5%
|
6 580 738
+2%
|
|
| Gross Profit | |||||||||||||||||||||||||||
| Cost of Revenue |
(1 648 645)
|
(1 688 739)
|
(1 704 483)
|
(1 764 499)
|
(1 798 124)
|
(1 854 515)
|
(2 004 685)
|
(2 088 188)
|
(2 050 429)
|
(2 134 149)
|
(2 281 499)
|
(2 442 670)
|
(2 730 666)
|
(2 911 143)
|
(2 924 631)
|
(2 926 569)
|
(2 957 488)
|
(3 024 076)
|
(3 193 422)
|
(3 333 023)
|
(3 449 246)
|
(3 572 751)
|
(3 709 051)
|
(3 900 258)
|
(4 039 572)
|
(4 172 951)
|
|
| Gross Profit |
1 263 168
N/A
|
1 313 989
+4%
|
1 353 608
+3%
|
1 449 005
+7%
|
1 532 695
+6%
|
1 603 035
+5%
|
1 626 255
+1%
|
1 625 102
0%
|
1 524 534
-6%
|
1 691 881
+11%
|
2 134 543
+26%
|
2 574 361
+21%
|
3 051 464
+19%
|
3 249 122
+6%
|
2 895 492
-11%
|
2 501 488
-14%
|
2 093 500
-16%
|
1 760 218
-16%
|
1 708 388
-3%
|
1 728 571
+1%
|
1 814 898
+5%
|
1 967 732
+8%
|
2 075 035
+5%
|
2 237 642
+8%
|
2 397 322
+7%
|
2 407 787
+0%
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(860 417)
|
(907 929)
|
(963 233)
|
(1 027 091)
|
(1 068 187)
|
(1 065 963)
|
(1 042 240)
|
(1 010 549)
|
(989 909)
|
(1 012 678)
|
(1 094 821)
|
(1 172 173)
|
(1 230 261)
|
(1 336 756)
|
(1 116 309)
|
(1 039 220)
|
(993 066)
|
(913 231)
|
(1 120 444)
|
(1 155 698)
|
(1 194 792)
|
(1 228 623)
|
(1 257 565)
|
(1 284 286)
|
(1 332 520)
|
(1 363 176)
|
|
| Selling, General & Administrative |
(752 978)
|
(815 800)
|
(880 200)
|
(934 905)
|
(973 016)
|
(989 560)
|
(995 787)
|
(977 634)
|
(965 106)
|
(1 013 595)
|
(1 096 806)
|
(1 187 025)
|
(1 249 138)
|
(1 331 306)
|
(1 164 141)
|
(1 093 367)
|
(1 055 162)
|
(995 248)
|
(1 067 223)
|
(1 069 341)
|
(1 074 328)
|
(1 105 607)
|
(1 131 987)
|
(1 140 231)
|
(1 182 230)
|
(1 168 723)
|
|
| Depreciation & Amortization |
(126 325)
|
(110 507)
|
(123 388)
|
(129 536)
|
(126 464)
|
(117 582)
|
(78 281)
|
(69 533)
|
(77 125)
|
(63 120)
|
(67 540)
|
(64 628)
|
(54 070)
|
(71 297)
|
(93 818)
|
(115 270)
|
(109 437)
|
(112 882)
|
(124 809)
|
(121 447)
|
(143 665)
|
0
|
(162 349)
|
(174 830)
|
(178 432)
|
(223 963)
|
|
| Other Operating Expenses |
18 886
|
18 378
|
40 355
|
37 350
|
31 293
|
41 179
|
31 828
|
36 618
|
52 322
|
64 037
|
69 525
|
79 480
|
72 947
|
65 847
|
141 650
|
169 417
|
171 533
|
194 899
|
71 588
|
35 090
|
23 201
|
(123 016)
|
36 771
|
30 775
|
28 142
|
29 510
|
|
| Operating Income |
402 751
N/A
|
406 060
+1%
|
390 375
-4%
|
421 914
+8%
|
464 508
+10%
|
537 072
+16%
|
584 015
+9%
|
614 553
+5%
|
534 625
-13%
|
679 203
+27%
|
1 039 722
+53%
|
1 402 188
+35%
|
1 821 203
+30%
|
1 912 366
+5%
|
1 779 183
-7%
|
1 462 268
-18%
|
1 100 434
-25%
|
846 987
-23%
|
587 944
-31%
|
572 873
-3%
|
620 106
+8%
|
739 109
+19%
|
817 470
+11%
|
953 356
+17%
|
1 064 802
+12%
|
1 044 611
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
(148 400)
|
(130 607)
|
(110 436)
|
(95 122)
|
(76 306)
|
(75 163)
|
(77 857)
|
(81 918)
|
(77 812)
|
(89 155)
|
(93 553)
|
(103 041)
|
(111 862)
|
(117 675)
|
(119 961)
|
(116 583)
|
(113 854)
|
(111 056)
|
(107 306)
|
(105 155)
|
(105 379)
|
(105 893)
|
(107 573)
|
(111 749)
|
(115 789)
|
(130 295)
|
|
| Non-Reccuring Items |
(3 444)
|
(5 499)
|
(4 401)
|
(3 589)
|
(3 075)
|
(1 082)
|
(682)
|
(840)
|
(943)
|
(571)
|
(159)
|
(50)
|
15
|
(332)
|
(1 020)
|
(1 272)
|
(1 509)
|
(1 501)
|
(550)
|
(83)
|
216
|
347
|
496
|
374
|
211
|
199
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
250 907
N/A
|
269 954
+8%
|
275 538
+2%
|
323 203
+17%
|
385 127
+19%
|
460 827
+20%
|
505 476
+10%
|
531 795
+5%
|
455 870
-14%
|
589 477
+29%
|
946 010
+60%
|
1 299 097
+37%
|
1 709 356
+32%
|
1 794 359
+5%
|
1 658 202
-8%
|
1 344 413
-19%
|
985 071
-27%
|
734 430
-25%
|
480 088
-35%
|
467 635
-3%
|
514 943
+10%
|
633 563
+23%
|
710 393
+12%
|
841 981
+19%
|
949 224
+13%
|
914 515
-4%
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
(102 723)
|
(82 073)
|
(84 514)
|
(108 482)
|
(130 816)
|
(167 303)
|
(161 556)
|
(162 956)
|
(140 282)
|
(160 721)
|
(300 372)
|
(385 982)
|
(483 023)
|
(493 347)
|
(358 428)
|
(266 304)
|
(185 960)
|
(123 983)
|
(101 315)
|
(96 881)
|
(96 089)
|
(128 359)
|
(151 109)
|
(175 645)
|
(202 181)
|
(199 385)
|
|
| Income from Continuing Operations |
148 184
|
187 881
|
191 024
|
214 721
|
254 311
|
293 524
|
343 920
|
368 839
|
315 588
|
428 756
|
645 638
|
913 115
|
1 226 333
|
1 301 012
|
1 299 774
|
1 078 109
|
799 111
|
610 447
|
378 773
|
370 754
|
418 854
|
505 204
|
559 284
|
666 336
|
747 043
|
715 130
|
|
| Income to Minority Interest |
(86 881)
|
(90 591)
|
(66 650)
|
(70 988)
|
(75 335)
|
(69 327)
|
(88 553)
|
(98 086)
|
(80 622)
|
(121 522)
|
(172 416)
|
(228 220)
|
(312 431)
|
(316 299)
|
(296 648)
|
(246 986)
|
(176 254)
|
(134 942)
|
(80 177)
|
(74 505)
|
(82 302)
|
(103 293)
|
(121 938)
|
(146 944)
|
(168 882)
|
(158 464)
|
|
| Net Income (Common) |
96 985
N/A
|
122 143
+26%
|
124 374
+2%
|
143 733
+16%
|
178 976
+25%
|
224 197
+25%
|
255 367
+14%
|
270 753
+6%
|
234 966
-13%
|
307 234
+31%
|
473 222
+54%
|
684 895
+45%
|
913 902
+33%
|
984 713
+8%
|
1 003 126
+2%
|
831 123
-17%
|
622 857
-25%
|
475 505
-24%
|
298 596
-37%
|
296 249
-1%
|
336 552
+14%
|
401 911
+19%
|
437 346
+9%
|
519 392
+19%
|
578 161
+11%
|
556 666
-4%
|
|
| EPS (Diluted) |
31.82
N/A
|
45.6
+43%
|
8.86
-81%
|
48.34
+446%
|
60.19
+25%
|
75.41
+25%
|
17.18
-77%
|
89.72
+422%
|
15.59
-83%
|
20.39
+31%
|
31.79
+56%
|
45.85
+44%
|
61.26
+34%
|
65.93
+8%
|
67.28
+2%
|
57.01
-15%
|
43.08
-24%
|
32.78
-24%
|
20.57
-37%
|
20.37
-1%
|
23.14
+14%
|
27.65
+19%
|
29.73
+8%
|
35.13
+18%
|
38.91
+11%
|
37.37
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
